LBA24 - A Randomised Phase Ii Study of Cediranib with or Without Src Inhibition (Saracatinib) in Metastatic Clear Cell Renal Cancer (Rcc) Patients Resistant to Vegf Targeted Therapy
| Autor: | Powles, T., Hawkins, R., Ralph, C., Larkin, J., Jones, R.J., Chowdhury, S., Boleti, E., Fife, K., Bahl, A., Crabb, S., Webb, A., Din, O.S., Dunlop, J., Hill, R., Geldart, T., McLaren, D., Nathan, P. |
|---|---|
| Zdroj: | In Annals of Oncology September 2014 25 Supplement 4:v1-v1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|